Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Letters in Applied Microbiology
|
September 13, 2003
Genetically modified filamentous phage as bactericidal agents: a pilot study
S Hagens, U Bläsi
Journal of Clinical Microbiology
|
March 1, 1992
Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II
C Cossen, S Hagens, R Fukuchi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 6, 2025
Mechanism-based drug safety testing using innovative <i>in vitro</i> liver models: from DILI prediction to idiosyncratic DILI liability assessment
Sibel Bahtiri, Tessa M S Hagens, Bob van de Water, et al.
Letters in Applied Microbiology
|
August 28, 2010
Bacteriophage applications: where are we now?
A B Monk, C D Rees, P Barrow, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1986
Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery
P H Azimi, R R Roberto, J Guralnik, et al.
Biofabrication
|
September 30, 2024
A microvascularized<i>in vitro</i>liver model for disease modeling and drug discovery
Flavio Bonanini, Roelof Dinkelberg, Manuel Caro Torregrosa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 2, 2024
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells
Cecilia Bergonzini, Alessandro Gregori, Tessa M S Hagens, et al.
The Journal of Animal Ecology
|
February 26, 2015
Space-use behaviour of woodland caribou based on a cognitive movement model
Tal Avgar, James A Baker, Glen S Brown, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Letters in Applied Microbiology
|
September 13, 2003
Genetically modified filamentous phage as bactericidal agents: a pilot study
S Hagens, U Bläsi
Journal of Clinical Microbiology
|
March 1, 1992
Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II
C Cossen, S Hagens, R Fukuchi, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
June 6, 2025
Mechanism-based drug safety testing using innovative <i>in vitro</i> liver models: from DILI prediction to idiosyncratic DILI liability assessment
Sibel Bahtiri, Tessa M S Hagens, Bob van de Water, et al.
Letters in Applied Microbiology
|
August 28, 2010
Bacteriophage applications: where are we now?
A B Monk, C D Rees, P Barrow, et al.
American Journal of Diseases of Children (1960)
|
January 1, 1986
Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery
P H Azimi, R R Roberto, J Guralnik, et al.
Biofabrication
|
September 30, 2024
A microvascularized<i>in vitro</i>liver model for disease modeling and drug discovery
Flavio Bonanini, Roelof Dinkelberg, Manuel Caro Torregrosa, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
January 2, 2024
ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells
Cecilia Bergonzini, Alessandro Gregori, Tessa M S Hagens, et al.
The Journal of Animal Ecology
|
February 26, 2015
Space-use behaviour of woodland caribou based on a cognitive movement model
Tal Avgar, James A Baker, Glen S Brown, et al.
Page
of 1